Related Experiment Videos
Chromosomal proteins in hepatocarcinogenesis.
Zeitschrift Fur Krebsforschung Und Klinische Onkologie. Cancer Research and Clinical Oncology
|January 1, 1978
Summary
Chromosomal protein changes in rat liver during nitrosomorpholine-induced cancer reveal altered nonhistone proteins and histone H1 degrees. Metastases show significant protein loss, including contractile proteins, and new protein expressions.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Chromosomal proteins play crucial roles in gene regulation and cellular processes.
- Hepatocarcinogenesis involves complex alterations in cellular and molecular components.
- Understanding protein changes during cancer development is vital for identifying biomarkers and therapeutic targets.
Purpose of the Study:
- To investigate alterations in rat liver chromosomal proteins during nitrosomorpholine-induced hepatocarcinogenesis.
- To compare protein profiles in primary hepatomas and their metastases.
- To identify specific protein changes associated with cancer progression.
Main Methods:
- Sodium dodecyl sulfate-gel electrophoresis (SDS-PAGE) for protein separation and analysis.
- Study of chromosomal proteins from control livers, carcinogen-treated livers, primary hepatomas, and metastases.
- Use of protease inhibitor phenylmethylsulfonyl fluoride (PMSF) to assess proteolytic activity.
Main Results:
- Increased proteolytic activity in carcinogen-treated livers altered nonhistone chromosomal proteins, reversible with PMSF.
- Primary hepatomas showed increased 43 kDa and 63 kDa proteins and decreased histone H1°.
- Metastases exhibited significant reduction of alpha-tubulin, beta-tubulin, and actin; increased 63 kDa protein; new proteins (approx. 60, 90, 120 kDa); and complete loss of histone H1°.
Conclusions:
- Nitrosomorpholine-induced hepatocarcinogenesis is associated with significant changes in chromosomal proteins.
- Specific protein alterations, including loss of contractile proteins and histone H1°, characterize metastatic liver cancer.
- These protein changes may serve as potential biomarkers for liver cancer progression.